Unknown

Dataset Information

Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time.


ABSTRACT:

Background

We explore whether the number of null results in large National Heart Lung, and Blood Institute (NHLBI) funded trials has increased over time.

Methods

We identified all large NHLBI supported RCTs between 1970 and 2012 evaluating drugs or dietary supplements for the treatment or prevention of cardiovascular disease. Trials were included if direct costs >$500,000/year, participants were adult humans, and the primary outcome was cardiovascular risk, disease or death. The 55 trials meeting these criteria were coded for whether they were published prior to or after the year 2000, whether they registered in clinicaltrials.gov prior to publication, used active or placebo comparator, and whether or not the trial had industry co-sponsorship. We tabulated whether the study

SUBMITTER: Kaplan RM 

PROVIDER: S-EPMC4526697 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature